Transcriptional Regulation of Siglec-15 by ETS-1 and ETS-2 in Hepatocellular Carcinoma Cells. [PDF]
Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) has been identified as a crucial immune suppressor in human cancers, comparable to programmed cell death 1 ligand (PD-L1).
Sheng K +6 more
europepmc +2 more sources
Anti-Siglec-15 Antibody Prevents Marked Bone Loss after Acute Spinal Cord Injury-Induced Immobilization in Rats. [PDF]
Peng Y +13 more
europepmc +1 more source
Core needle biopsies alter the amounts of CCR5, Siglec-15, and PD-L1 positivities in breast carcinoma. [PDF]
Mutka M +4 more
europepmc +1 more source
Immune checkpoint blockade targeting the programmed cell death protein-1 (PD-1) and its ligand PD-L1 has revolutionized cancer immunotherapy; however, a substantial proportion of patients exhibit primary or acquired resistance, underscoring the existence
WANG Shihui, ZHENG Tianqing
doaj
Siglec-15 Expression in Gastric Carcinoma and Its Association With Clinicopathological Variables. [PDF]
Al Badr S +5 more
europepmc +1 more source
Enhancing the Anti-tumor Potency of a Novel Siglec-15 Antibody by Engineering its Fc-mediated Effector Functions. [PDF]
Ding H +7 more
europepmc +1 more source
Association between DPAGT1 and Siglec-15 expression and the malignant phenotype of hepatocellular carcinoma. [PDF]
Luo M +5 more
europepmc +1 more source
Siglec‑15 dysregulation and its therapeutic implications in new‑onset type 1 diabetes. [PDF]
Guo H +6 more
europepmc +1 more source
Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. [PDF]
Shafi S +11 more
europepmc +1 more source
Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence. [PDF]
Cui L +9 more
europepmc +1 more source

